We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

53 hedge funds and large institutions have $298M invested in Aerie Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

18% more capital invested

Capital invested by funds: $252M → $298M (+$46.5M)

8% more funds holding

Funds holding: 49 → 53 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
23
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$5.36M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.29M
3
IHM
Iguana Healthcare Management
New York
+$1.97M
4
MSA
Mason Street Advisors
Wisconsin
+$1.81M
5
CNB
City National Bank
California
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$7.03M
2
GPP
Great Point Partners
Connecticut
-$5.54M
3
Millennium Management
Millennium Management
New York
-$1.92M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.8M
5
PA
Perceptive Advisors
New York
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$905K +$858K +42,452 +15,437%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$697K +$187K +9,261 +39%
BA
28
BlackRock Advisors
Delaware
$694K +$328K +16,210 +98%
IMS
29
Index Management Solutions
Pennsylvania
$655K +$624K +30,892 New
TCIM
30
TIAA CREF Investment Management
New York
$550K +$119K +5,900 +29%
NFA
31
Nationwide Fund Advisors
Ohio
$534K +$392K +19,398 +335%
BIM
32
BlackRock Investment Management
Delaware
$477K +$56.7K +2,806 +14%
TC
33
TFS Capital
Pennsylvania
$421K +$401K +19,855 New
CS
34
Credit Suisse
Switzerland
$370K +$352K +17,434 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$297K – – –
TA
36
Teachers Advisors
New York
$262K +$95.8K +4,740 +62%
Charles Schwab
37
Charles Schwab
California
$238K – – –
CBOA
38
Commonwealth Bank of Australia
Australia
$233K +$6.06K +300 +3%
PP
39
PDT Partners
New York
$227K +$217K +10,734 New
Deutsche Bank
40
Deutsche Bank
Germany
$146K -$488K -24,133 -78%
AIG
41
American International Group
New York
$111K +$2.55K +126 +2%
Morgan Stanley
42
Morgan Stanley
New York
$105K -$351K -17,374 -78%
Citigroup
43
Citigroup
New York
$80K +$61 +3 +0.1%
SO
44
STRS Ohio
Ohio
$32K -$32.3K -1,600 -52%
BJ
45
BlackRock Japan
Japan
$22K +$21.2K +1,049 New
RNS
46
Robert N. Shapiro
$19K +$17.9K +888 New
GXMC
47
Global X Management Company
New York
$19K +$18.4K +909 New
U
48
UBS
Switzerland
$17K -$4.69K -232 -23%
Wells Fargo
49
Wells Fargo
California
$11K +$10.1K +500 New
Barclays
50
Barclays
United Kingdom
$6K +$3.68K +182 +149%
1
2
3

AERI Hedge Fund Activity: Q1 2014 in Review

53 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2014, worth a combined $298M — up 18% from $252M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AERI positions and 9 closed out — a net gain of 4 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was Deerfield Management, adding an estimated $5.36M. The largest seller was Broadfin Capital, exiting entirely with an estimated $7.03M sold.

  • 53 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2014, up from 49 in Q4 2013.
  • Funds reported $298M of Aerie Pharmaceuticals stock for Q1 2014, up 18% quarter-over-quarter.
  • 13 funds opened new Aerie Pharmaceuticals positions in Q1 2014 and 9 closed out, a net change of +4 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2014 was Deerfield Management, an estimated $5.36M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2014 was Broadfin Capital, an estimated $7.03M sold.

Based on aggregated 13F filings for Q1 2014.